Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives

Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives

US Patent 10653753 · Granted May 19, 2020

Estimated economic value: $4,843,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of using buffered formulations of exendin (9-39)2023
Methods for the treatment of non-alcoholic steatohepatitis2023
Camera optical lens including six lenses of +−−−+− refractive powers2022
Camera optical lens including six lenses of +−−++−refractive powers2022
Camera optical lens including seven lenses of ++−−−+− or ++−−−++ refractive powe2022
Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives2021
Buffered formulations of exendin (9-39)2021
Terminal back cover and mobile terminal2021
Methods and pharmaceutical compositions for the treatment of non-alcoholic steat2020
Terminal casing and terminal2019
Terminal housing and terminal2019
Antenna module and electronic device including the same2019